203 related articles for article (PubMed ID: 29915028)
21. Atomic detail of chemical transformation at the transition state of an enzymatic reaction.
Saen-Oon S; Quaytman-Machleder S; Schramm VL; Schwartz SD
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16543-8. PubMed ID: 18946041
[TBL] [Abstract][Full Text] [Related]
22. Connecting Conformational Motions to Rapid Dynamics in Human Purine Nucleoside Phosphorylase.
Frost CF; Balasubramani SG; Antoniou D; Schwartz SD
J Phys Chem B; 2023 Jan; 127(1):144-150. PubMed ID: 36538016
[TBL] [Abstract][Full Text] [Related]
23. Transition state analysis for human and Plasmodium falciparum purine nucleoside phosphorylases.
Lewandowicz A; Schramm VL
Biochemistry; 2004 Feb; 43(6):1458-68. PubMed ID: 14769022
[TBL] [Abstract][Full Text] [Related]
24. Energetic mapping of transition state analogue interactions with human and Plasmodium falciparum purine nucleoside phosphorylases.
Lewandowicz A; Ringia EA; Ting LM; Kim K; Tyler PC; Evans GB; Zubkova OV; Mee S; Painter GF; Lenz DH; Furneaux RH; Schramm VL
J Biol Chem; 2005 Aug; 280(34):30320-8. PubMed ID: 15961383
[TBL] [Abstract][Full Text] [Related]
25. Neighboring group participation in the transition state of human purine nucleoside phosphorylase.
Murkin AS; Birck MR; Rinaldo-Matthis A; Shi W; Taylor EA; Almo SC; Schramm VL
Biochemistry; 2007 May; 46(17):5038-49. PubMed ID: 17407325
[TBL] [Abstract][Full Text] [Related]
26. Conformational states of human purine nucleoside phosphorylase at rest, at work, and with transition state analogues.
Edwards AA; Tipton JD; Brenowitz MD; Emmett MR; Marshall AG; Evans GB; Tyler PC; Schramm VL
Biochemistry; 2010 Mar; 49(9):2058-67. PubMed ID: 20108972
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
Bzowska A; Koellner G; Wielgus-Kutrowska B; Stroh A; Raszewski G; Holý A; Steiner T; Frank J
J Mol Biol; 2004 Sep; 342(3):1015-32. PubMed ID: 15342253
[TBL] [Abstract][Full Text] [Related]
28. Anopheles gambiae purine nucleoside phosphorylase: catalysis, structure, and inhibition.
Taylor EA; Rinaldo-Matthis A; Li L; Ghanem M; Hazleton KZ; Cassera MB; Almo SC; Schramm VL
Biochemistry; 2007 Oct; 46(43):12405-15. PubMed ID: 17918964
[TBL] [Abstract][Full Text] [Related]
29. Loop-tryptophan human purine nucleoside phosphorylase reveals submillisecond protein dynamics.
Ghanem M; Zhadin N; Callender R; Schramm VL
Biochemistry; 2009 Apr; 48(16):3658-68. PubMed ID: 19191546
[TBL] [Abstract][Full Text] [Related]
30. Transition states and inhibitors of the purine nucleoside phosphorylase family.
Taylor Ringia EA; Schramm VL
Curr Top Med Chem; 2005; 5(13):1237-58. PubMed ID: 16305529
[TBL] [Abstract][Full Text] [Related]
31. Active site contacts in the purine nucleoside phosphorylase--hypoxanthine complex by NMR and ab initio calculations.
Deng H; Cahill SM; Abad JL; Lewandowicz A; Callender RH; Schramm VL; Jones RA
Biochemistry; 2004 Dec; 43(50):15966-74. PubMed ID: 15595853
[TBL] [Abstract][Full Text] [Related]
32. New catalytic mechanism for human purine nucleoside phosphorylase.
Canduri F; Fadel V; Basso LA; Palma MS; Santos DS; de Azevedo WF
Biochem Biophys Res Commun; 2005 Feb; 327(3):646-9. PubMed ID: 15649395
[TBL] [Abstract][Full Text] [Related]
33. [Purine nucleoside phosphorylase].
Pogosian LG; Akopian ZhI
Biomed Khim; 2013; 59(5):483-97. PubMed ID: 24479338
[TBL] [Abstract][Full Text] [Related]
34. Probing the mechanism of purine nucleoside phosphorylase by steady-state kinetic studies and ligand binding characterization determined by fluorimetric titrations.
Wielgus-Kutrowska B; Bzowska A
Biochim Biophys Acta; 2006 May; 1764(5):887-902. PubMed ID: 16631420
[TBL] [Abstract][Full Text] [Related]
35. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
[TBL] [Abstract][Full Text] [Related]
36. Insight into catalytically relevant correlated motions in human purine nucleoside phosphorylase.
Núñez S; Wing C; Antoniou D; Schramm VL; Schwartz SD
J Phys Chem A; 2006 Jan; 110(2):463-72. PubMed ID: 16405318
[TBL] [Abstract][Full Text] [Related]
37. Ionic states of substrates and transition state analogues at the catalytic sites of N-ribosyltransferases.
Sauve AA; Cahill SM; Zech SG; Basso LA; Lewandowicz A; Santos DS; Grubmeyer C; Evans GB; Furneaux RH; Tyler PC; McDermott A; Girvin ME; Schramm VL
Biochemistry; 2003 May; 42(19):5694-705. PubMed ID: 12741826
[TBL] [Abstract][Full Text] [Related]
38. Enzymatic transition states and dynamic motion in barrier crossing.
Schwartz SD; Schramm VL
Nat Chem Biol; 2009 Aug; 5(8):551-8. PubMed ID: 19620996
[TBL] [Abstract][Full Text] [Related]
39. Catalytic site conformations in human PNP by 19F-NMR and crystallography.
Suarez J; Haapalainen AM; Cahill SM; Ho MC; Yan F; Almo SC; Schramm VL
Chem Biol; 2013 Feb; 20(2):212-22. PubMed ID: 23438750
[TBL] [Abstract][Full Text] [Related]
40. Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase.
Donaldson TM; Cassera MB; Ho MC; Zhan C; Merino EF; Evans GB; Tyler PC; Almo SC; Schramm VL; Kim K
Eukaryot Cell; 2014 May; 13(5):572-9. PubMed ID: 24585883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
